EQIX
45
-2
EL
27
-3
ADP
76
3
PG
73
5
MET
70
4
NWL
25
3
ECL
67
2
TRV
55
6
AEP
77
2
WBA
40
-3
EIX
47
7
UAL
61
4
ZTS
9
4
ETR
68
7
MHK
36
-3
MO
69
3
C
57
2
FLS
55
5
TMO
43
3
RHI
24
2
EQIX
45
-2
EL
27
-3
ADP
76
3
PG
73
5
MET
70
4
NWL
25
3
ECL
67
2
TRV
55
6
AEP
77
2
WBA
40
-3
EIX
47
7
UAL
61
4
ZTS
9
4
ETR
68
7
MHK
36
-3
MO
69
3
C
57
2
FLS
55
5
TMO
43
3
RHI
24
2
Financhill
Back

Northann Vs. Sarepta Therapeutics Industry Stock Comparison

Sell
5

NCL
Northann

Last Price:
$0.20
Seasonality Move:
-46.27%
Buy
57

SRPT
Sarepta Therapeutics

Last Price:
$106.83
Seasonality Move:
8.04%
Sell
5
Northann (NCL) is a Sell

Is Northann a Buy, Sell or Hold?

  • The current Northann [NCL] share price is $0.20. The Score for NCL is 5, which is 90% below its historic median score of 50, and infers higher risk than normal.
  • NCL is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Buy
57
Sarepta Therapeutics (SRPT) is a Buy

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $106.89. The Score for SRPT is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
  • SRPT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

NCL Stock Price Chart

What is Northann's stock price today?

  • The Northann share price today is $0.20
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NCL is experiencing slight buying pressure.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $106.89
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing slight buying pressure.

NCL Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 31.39 Sell
Chaikin Money Flow: 108679 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.23 - 0.29) Sell
Bollinger Bands (100): (0.2 - 0.3) Sell

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -3.25 Sell
Relative Strength Index (14 RSI): 41.97 Sell
Chaikin Money Flow: 469170 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (106.93 - 115.87) Sell
Bollinger Bands (100): (111.92 - 127.28) Sell

NCL Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.22 Sell
20-day SMA: 0.25 Sell
50-day SMA: 0.27 Sell
200-day SMA: 0.25 Sell
8-day EMA: 0.22 Sell
20-day EMA: 0.24 Sell
50-day EMA: 0.26 Sell
200-day EMA: 0.8 Sell

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 106.35 Buy
20-day SMA: 109.97 Sell
50-day SMA: 116.57 Sell
200-day SMA: 127.54 Sell
8-day EMA: 106.76 Buy
20-day EMA: 109.7 Sell
50-day EMA: 114.67 Sell
200-day EMA: 122.08 Sell

Northann Earnings Growth & NCL Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.86 per share, a decrease next quarter of $0.29 per share, an increase this year of $7.95 per share, and an increase next year of $4.16 per share.

Northann Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):